About ICIMED Instituto de Investigación en Ciencias Médicas
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
14
Clinical Trials at ICIMED Instituto de Investigación en Ciencias Médicas
During the past decade, ICIMED Instituto de Investigación en Ciencias Médicas conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on
average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
2019-10-10
2023-07-07
Recruiting
3,160
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at ICIMED Instituto de Investigación en Ciencias Médicas
According to Clinical.Site data, the most researched conditions in "ICIMED Instituto de Investigación en Ciencias Médicas" are
"Influenza" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Alzheimer's Disease" (1 trials), "Breast Cancer" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "ICIMED Instituto de Investigación en Ciencias Médicas" in a lesser frequency.
Clinical Trials Intervention Types at ICIMED Instituto de Investigación en Ciencias Médicas
Most popular intervention types in "ICIMED Instituto de Investigación en Ciencias Médicas" are "Drug" (13 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (4 trials), "Baloxavir Marboxil" (3 trials), "Ipatasertib" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ICIMED Instituto de Investigación en Ciencias Médicas
The vast majority of trials in "ICIMED Instituto de Investigación en Ciencias Médicas" are
12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at ICIMED Instituto de Investigación en Ciencias Médicas
Currently, there are NaN active trials in "ICIMED Instituto de Investigación en Ciencias Médicas".
undefined are not yet recruiting,
7 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in ICIMED Instituto de Investigación en Ciencias Médicas,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ICIMED Instituto de Investigación en Ciencias Médicas, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".